What is Moonlight AI?
Moonlight AI operates at the intersection of artificial intelligence and clinical diagnostics, specializing in the extraction of actionable genomic and molecular data from standard hematology and cytology imaging. By automating the analysis of routine samples, the platform provides diagnostic laboratories with a scalable solution to triage molecular testing more effectively. This technological approach not only enhances the speed of diagnostic reporting but also empowers clinicians to make more informed, precision-based decisions for patient care. The company's core value proposition lies in its ability to bridge the gap between traditional pathology and modern molecular insights, effectively reducing the burden on laboratory infrastructure while improving diagnostic accuracy.
How much funding has Moonlight AI raised?
Moonlight AI has raised a total of $3.3M across 1 funding round:
Seed
$3.3M
Seed (2026): $3.3M with participation from VP Venture Partners, N & V Capital, and QAI Ventures
Key Investors in Moonlight AI
VP Venture Partners
A Zurich-based venture capital firm specializing in early-stage life science companies, focusing on deep tech ventures including medical devices and diagnostics.
N & V Capital
A family-owned venture capital boutique that provides financial support and practical guidance to early-stage startups in digital health and scientific innovation.
QAI Ventures
A Basel-based venture capital firm and accelerator dedicated to advancing global quantum technology and AI solutions through early-stage funding and ecosystem building.
What's next for Moonlight AI?
Looking ahead, the strategic roadmap for Moonlight AI involves expanding its diagnostic capabilities and deepening its integration within existing laboratory information systems. The recent capital injection will likely be deployed toward enhancing the platform's machine learning models, ensuring they remain at the forefront of diagnostic innovation. Furthermore, the company is expected to focus on regulatory milestones and clinical validation studies, which are essential for broader market adoption. As the firm scales, it will likely prioritize strategic partnerships with major healthcare providers and diagnostic networks to facilitate the widespread implementation of its AI-driven triage tools, ultimately aiming to set a new standard for efficiency in precision medicine.
See full Moonlight AI company page
